Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ArcelorMittal announces the publication of its third quarter 2024 sell-side analyst consensus figures
-
New report demands greater understanding of the impact of change on academia
-
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
-
Sai Life Sciences receives EIRs from USFDA for India R&D & Manufacturing facilities
-
Share buyback programme - week 43
-
Global Times: How some residents in East China's Fujian resolved their decade-long neighborhood conflicts with wisdom of whole-process people's democracy
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Form 8.5 (EPT/RI) Brown (N.) Group plc
-
Hong Kong Films @ Tokyo 2024
-
Form 8.5 (EPT/RI) - Eckoh Plc
-
3Aware and RQM+ Forge Partnership to Enhance MedTech Compliance and Innovation
-
Bank of Åland Plc: Managers' Transactions (Erikslund)
-
SHARE BUYBACK TRANSACTIONS
-
Prepayments, Realkredit Danmark A/S
-
Remarks by IMF Managing Director Kristalina Georgieva at the 2024 ESG Global Leaders Conference
-
AlzeCure Presents New Positive Data for the TrkA-NAM Pain Project Against Osteoarthritis
-
2024 "Nanjing Week" Kicks Off in France: "Brocade and Embroidery " Shines in Paris
-
2024 "Nanjing Week" Kicks Off in France: "Brocade and Embroidery " Shines in Paris
-
Heimar hf.: Regular Notification of Share Buybacks in Accordance with the Buyback Program
-
Rooting for a Drug-Free World at the Roller Hockey Championships
-
Sydbank share buyback programme: transactions in week 43
-
WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development
-
Baidu to Report Third Quarter 2024 Financial Results on Nov 21, 2024
-
CluePoints Appoints Richard Young as Chief Strategy Officer
-
Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
-
FullCircl Releases 2025 State of Identify Verification Report
-
Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy for the Treatment of Peanut Allergy
-
Insight Partners Acquires Majority Stake in Detectify
-
AD Ports Group Is a Leading Driver of Economic Diversification and Non-Oil GDP in Abu Dhabi and UAE: New Study
-
Business Email Compromise (BEC) Impersonation: The Weapon of Choice of Cybercriminals, Finds VIPRE's Q3 2024 Email Threat Report
-
NextGen Growth Partners Announces Key Promotions as Fund III Gains Momentum
-
DigitalBridge to Acquire Yondr Group
-
Transition Industries LLC and Mitsubishi Gas Chemical announce Letter of Intent for a long-term Methanol Sales Agreement from the Pacifico Mexinol project in Sinaloa, Mexico
-
iQIYI to Report Third Quarter 2024 Financial Results on November 21, 2024
-
FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot
-
Levicept to Present Phase II Data at ACR Convergence 2024
-
Danske Bank share buy-back programme: Transactions in week 43
-
NEC launches new end to end private 5G solution with Cisco
-
Form 8.5 (EPT/RI) - Brown (N) Group Plc
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
CNOOC Limited Achieves Record High Net Production and Net Profit in Q3 2024
-
Zoomcar to Announce Second Quarter 2024 Financial Results on 14 November 2024
-
Biban24 creates innovative "Doors" of opportunity for SMEs and entrepreneurs from around the world to explore
-
Consensus estimates ahead of Q3 2024
-
Socha Companies Expands Manchester, NH Housing Options with Grand Opening of Saddle Rock
-
Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic
-
Cerillion Transforms Digital Engagement with Next-Gen Self Service
-
Digitalist Group structures its financing
-
Alm. Brand A/S – Weekly report on share buybacks
-
Preliminary data on early redemptions (prepayments)
